Article Details
Retrieved on: 2024-06-21 21:41:36
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article describes Novotech's report on the rapid growth and promising future of Antibody-Drug Conjugates (ADCs) in biotech, emphasizing their impact on cancer treatment, clinical trials, and investment trends. This ties into the key concept 'Biotech' and tags like 'Antibody-drug conjugates', 'Targeted therapy', and 'Clinical trial'.
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here